Tocopherol and tocotrienol aerosols
View Patent ↗Anti-inflammatory compositions include medicaments comprising predetermined amounts of a phytyl substituted chromanol and a prostaglandin E 2 inhibitor, wherein: said medicament is in unit dosage form suitable for pharmaceutical administration; said phytyl substituted chromanol is a gamma-tocopherol, delta-tocopherol, gamma-tocotrienol or delta-tocotrienol; said PGE 2 inhibitor is a non-steroidal anti-inflammatory drug or an omega-3 fatty acid, such as docosahexaenoic acid and eicosapentaenoic acid.
1. A method of inhibiting proliferation of human prostate epithelial cancer cells or human lung epithelial cancer cells in a person, the method comprising administering to the person in unit dosage form a medicament consisting of 150 mg gamma-tocopherol, 150 mg gamma-tocotrienol, 50 mg acetaminophen, and one or more carrier, vehicle or excipient suitable for use in pharmaceutical compositions.
2. The method of claim 1 wherein the cells are the human prostate epithelial cancer cells and the medicament is administered orally.
3. The method of claim 1 wherein the cells are the human lung epithelial cancer cells and the medicament is administered as an inhalant.
4. A method of inhibiting proliferation of human prostate epithelial cancer cells or human lung epithelial cancer cells in a person, the method comprising administering to the person in unit dosage form a medicament consisting of 150 mg gamma-tocopherol, 150 mg gamma-tocotrienol, 50 mg aspirin, and one or more carrier, vehicle or excipient suitable for use in pharmaceutical compositions.
5. The method of claim 4 wherein the cells are the human prostate epithelial cancer cells and the medicament is administered orally.
6. The method of claim 4 wherein the cells are the human lung epithelial cancer cells and the medicament is administered as an inhalant.